Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-12-06
2005-12-06
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235200, C514S266400, C514S313000, C544S119000, C544S128000, C544S293000, C546S159000, C546S160000
Reexamination Certificate
active
06972288
ABSTRACT:
The present invention relates to bicyclic heterocycles of general formulawhereinRato Rd, A to G and X are defined as in claim 1, the tautomers, the steroisomers and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases which have valuable pharmacological properties, particularly an inhibiting effect on signal transduction mediated by tyrosine kinases, their use for treating diseases, particularly tumoral diseases, diseases of the lungs and respiratory tract, and the preparation thereof.
REFERENCES:
patent: 6002008 (1999-12-01), Wissner et al.
patent: 6384051 (2002-05-01), Frost et al.
patent: 6403580 (2002-06-01), Himmelsbach et al.
patent: 6653305 (2003-11-01), Himmelsbach et al.
patent: 6740651 (2004-05-01), Himmelsbach et al.
patent: 0 787 722 (1997-08-01), None
patent: WO96 33980 (1996-10-01), None
patent: WO97 30035 (1997-08-01), None
patent: WO97 32856 (1997-09-01), None
patent: WO98 13354 (1998-04-01), None
patent: WO 98-43960 (1998-10-01), None
patent: WO99 09016 (1999-02-01), None
patent: WO00 18740 (2000-04-01), None
patent: WO00 55141 (2000-09-01), None
Boschelli; “Small molecule inhibitors of receptor tyrosine kinases”; Review Article—Chemical Sciences, Drugs of the Future, vol. 24, No. 5, 1999, pp. 515-537.
Blech Stefan
Himmelsbach Frank
Jung Birgit
Langkopf Elke
Metz Thomas
Boehringer Ingelheim Pharma KG
Devlin Mary-Ellen M.
Morris Michael P.
Raymond Richard L.
Stempel Alan R.
LandOfFree
4-amino-quinazoline and quinoline derivatives having an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-amino-quinazoline and quinoline derivatives having an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-amino-quinazoline and quinoline derivatives having an... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3517659